Bernard J. Zovighian, CEO at Edwards Lifesciences Corp (EW), sold 17,234 shares at $87.68 ($1.5M) on 2024-05-30, disclosed to the SEC on 2024-05-30.
Scheduled sale ($1.5M) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $87.68 | 8,617 | $756K | 50.0% |
| 2 | $87.68 | 8,617 | $756K | 50.0% |
| Total | $87.68 avg | 17,234 | $1.5M | 100% |
| Filing → |
| EW | SELL | 2026-05-12 | $2.8M | — | Filing → |
| EW | SELL | 2026-02-13 | $3.4M | — | Filing → |
| EW | SELL | 2025-12-10 | $4.3M | — | Filing → |